Sym004

· Symphogen A/S

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Sym004, covering 2016-02-02 to 2020-07-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study of Sym004 for Adult Patients With Recurrent Glioblastoma [Phase 2]